Answers are grounded in this paper and cite their sources.
Validation study demonstrates the utility of the ACE-III for detecting cognitive deficits in frontotemporal dementia and Alzheimer's disease, highlighting its value as an objective screening tool.
The results of this study provide objective validation of the ACE-III as a screening tool for cognitive deficits in FTD and AD.
No takes yet. Share an insight, caveat, or question.
Hsieh et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: